Literature DB >> 6361154

The use of cytocentrifuge preparations for the demonstration of T cell surface antigens.

M Salmon, P A Bacon, G D Johnson, L Walker, K W Walton.   

Abstract

Cytocentrifuged cell preparations have been evaluated as substrates for the demonstration by immunofluorescence of T cell surface antigens. Results obtained by a 2-stage method with fluorescent conjugate specific for the isotype of the first stage monoclonal antibody, and by a 3-stage procedure employing an intermediate antiserum to mouse IgG as amplifying agent, showed good correlation with those obtained by a standard technique performed on cells in suspension. These methods have the advantages of requiring fewer cells and less antibody and the cytocentrifuge preparations may be stored for batch assay.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6361154     DOI: 10.1016/0022-1759(84)90345-4

Source DB:  PubMed          Journal:  J Immunol Methods        ISSN: 0022-1759            Impact factor:   2.303


  5 in total

1.  Transferrin receptor expression by stimulated cells in mixed lymphocyte culture.

Authors:  M Salmon; P A Bacon; D P Symmons; K W Walton
Journal:  Immunology       Date:  1985-03       Impact factor: 7.397

2.  Transferrin receptor bearing cells in the peripheral blood of patients with rheumatoid arthritis.

Authors:  M Salmon; P A Bacon; D P Symmons; A D Blann
Journal:  Clin Exp Immunol       Date:  1985-11       Impact factor: 4.330

3.  B lymphocyte activation by insoluble anti-mu antibodies in patients with systemic lupus erythematosus.

Authors:  H Becker; U Schauer; K Helmke
Journal:  Clin Exp Immunol       Date:  1986-11       Impact factor: 4.330

4.  Lymphocyte sub-populations and NSAIDs. Methodological aspects.

Authors:  P A Bacon; M Salmon; A Blann; D G Scott; M Farr
Journal:  Inflammation       Date:  1984-06       Impact factor: 4.092

5.  Lymphopenia in rheumatoid arthritis.

Authors:  D P Symmons; M Farr; M Salmon; P A Bacon
Journal:  J R Soc Med       Date:  1989-08       Impact factor: 18.000

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.